aminolevulinic acid has been researched along with Esophageal Neoplasms in 52 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eleven patients with high-grade mucosal dysplasia in a columnar-lined oesophagus and 2 patients with a squamous carcinoma (uT1) underwent photodynamic therapy (PDT) and argon-plasma coagulation (APC)." | 3.70 | [Photodynamic ablation and argon-plasma coagulation of premalignant and early-stage malignant lesions of the oesophagus--an alternative to surgery?]. ( Beger, HG; Orth, K; Rück, A; Russ, D; Stanescu, A, 1999) |
| "Four patients with known gastric adenoma (n = 1), macroscopically undetected but histologically proven esophageal squamous cell cancer (n = 1), suspected early cancer of the esophagus (n = 1), and multiple duodenal adenomas (n = 1) were sensitized with 5-aminolevulinic acid administered orally (15 mg/kg body weight)." | 3.70 | Endoscopic photodynamic diagnosis: oral aminolevulinic acid is a marker of GI cancer and dysplastic lesions. ( Hahn, EG; Hochberger, J; Mayinger, B; Reh, H, 1999) |
| "Improvement regarding dysphagia, stenosis diameter, and tumor length could be obtained in both treatment arms with a significant difference in favour of the Photosan-group, P = 0." | 2.70 | Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma? ( Maier, A; Matzi, V; Pinter, H; Rehak, P; Smolle-Jüttner, FM; Tomaselli, F, 2001) |
| "Two patients had squamous cell carcinoma of the mid-esophagus and three had adenocarcinoma of the distal esophagus." | 2.69 | Photodynamic therapy of cancer of the esophagus using systemic aminolevulinic acid and a non laser light source: a phase I/II study. ( Haddad, R; Kashtan, H; Konikoff, F; Skornick, Y, 1999) |
| "Surveillance of Barrett's esophagus is routinely undertaken to detect early malignant transformation." | 2.42 | 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus. ( Ackroyd, R; Claydon, PE, 2004) |
| "Barrett's esophagus is a precursor of adenocarcinoma of the esophagus." | 2.42 | 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus. ( Ackroyd, R; Claydon, PE, 2004) |
| "DHA might increase the sensitivity of esophageal cancer cells to PDT by inhibiting the NF-κB/HIF-1α/VEGF pathway." | 1.48 | Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo. ( Bai, Y; Du, J; Du, X; Han, Y; Huang, P; Jiang, C; Li, S; Li, Y; Sui, H, 2018) |
| "Early superficial (< 3 mm) squamous cell carcinomas of the esophagus can be ablated completely by 5-ALA-PDT." | 1.33 | Long-Segment early squamous cell carcinoma of the proximal esophagus: curative treatment and long-term follow-up after 5-aminolevulinic acid (5-ALA)-photodynamic therapy. ( Alsenbesy, M; Eickhoff, A; Eickhoff, JC; Hartmann, D; Jakobs, R; Riemann, JF; Schilling, D; Weickert, U, 2006) |
| "Hypericin is a very promising new photosensitizer for innovative photodynamic therapy of esophageal cancer." | 1.32 | Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells. ( Höpfner, M; Kashtan, H; Lenz, M; Maaser, K; Riecken, EO; Scherübl, H; Sutter, AP; Theiss, A; von Lampe, B; Zeitz, M, 2003) |
| "Barrett's esophagus is strongly associated with adenocarcinoma." | 1.32 | Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid. ( Dorta, G; Felley, C; Fontolliet, C; Gabrecht, T; Grosjean, P; Jornod, P; Lange, N; Monnier, P; Stepinac, T; van den Bergh, H; vanMelle, G; Wagnières, G, 2003) |
| "14 patients with histologically proven Barrett's esophagus, seven of whom had evidence of low-grade dysplasia, underwent endoscopic treatment with topical delta-ALA." | 1.31 | Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. ( Dietel, M; Ebert, B; Fleige, B; Liebetruth, J; Lochs, H; Ortner, M-; Zumbusch, K, 2002) |
| "Barrett's esophagus is a complication of gastroesophageal reflux disease (GERD) characterized by specialized columnar epithelium that contains goblet cells and replaces the squamous epithelium of the distal esophagus." | 1.31 | [Endoscopic fluorescence diagnosis of esophageal carcinoma after sensitization with 5-aminolevulinic acid]. ( Endlicher, E; Fürst, A; Knüchel, R; Messmann, H; Schölmerich, J, 2001) |
| "Eight patients with Barrett's esophagus and/or early cancer were treated." | 1.31 | [Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system--a pilot study]. ( Apel, D; Arnold, JC; Jakobs, R; Riemann, JF; Rosenbaum, A; Zöpf, T, 2001) |
| "PDT of Barrett's esophagus with severe dysplasia, or of mucosal carcinomas and superficial squamous-cell cancer of the esophagus, requires light application devices allowing homogeneous illumination of the tissue surface in spite of esophageal motility and respiratory movement." | 1.30 | A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. ( Ell, C; Gossner, L; May, A; Sroka, R, 1999) |
| "4 had squamous cell carcinoma of the mid-esophagus and 4 had adenocarcinoma of the lower esophagus." | 1.30 | [Photodynamic therapy for dysphagia due to esophageal carcinoma]. ( Haddad, R; Halpern, Z; Kashtan, H; Konikoff, F; Skornick, Y; Umansky, M, 1999) |
| "The degree of dysphagia was recorded before and 14 days after treatment." | 1.30 | [Photodynamic therapy for dysphagia due to esophageal carcinoma]. ( Haddad, R; Halpern, Z; Kashtan, H; Konikoff, F; Skornick, Y; Umansky, M, 1999) |
| "Dysphagia was improved in all except 1 patient." | 1.30 | [Photodynamic therapy for dysphagia due to esophageal carcinoma]. ( Haddad, R; Halpern, Z; Kashtan, H; Konikoff, F; Skornick, Y; Umansky, M, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (36.54) | 18.2507 |
| 2000's | 23 (44.23) | 29.6817 |
| 2010's | 8 (15.38) | 24.3611 |
| 2020's | 2 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Beika, M | 1 |
| Harada, Y | 1 |
| Minamikawa, T | 1 |
| Yamaoka, Y | 1 |
| Koizumi, N | 1 |
| Murayama, Y | 1 |
| Konishi, H | 1 |
| Shiozaki, A | 1 |
| Fujiwara, H | 1 |
| Otsuji, E | 1 |
| Takamatsu, T | 1 |
| Tanaka, H | 1 |
| Shishido, Y | 1 |
| Amisaki, M | 1 |
| Matsumi, Y | 1 |
| Yakura, H | 1 |
| Nakayama, Y | 1 |
| Miyauchi, W | 1 |
| Miyatani, K | 1 |
| Matsunaga, T | 1 |
| Hanaki, T | 1 |
| Kihara, K | 1 |
| Yamamoto, M | 1 |
| Tokuyasu, N | 1 |
| Takano, S | 1 |
| Sakamoto, T | 1 |
| Honjo, S | 1 |
| Hasegawa, T | 1 |
| Fujiwara, Y | 1 |
| Zhang, X | 1 |
| Cai, L | 1 |
| He, J | 1 |
| Li, X | 1 |
| Li, L | 2 |
| Chen, X | 2 |
| Lan, P | 1 |
| Kohoutova, D | 1 |
| Haidry, R | 2 |
| Banks, M | 1 |
| Butt, MA | 1 |
| Dunn, J | 2 |
| Thorpe, S | 2 |
| Lovat, L | 2 |
| Li, Y | 1 |
| Sui, H | 1 |
| Jiang, C | 1 |
| Li, S | 1 |
| Han, Y | 1 |
| Huang, P | 1 |
| Du, X | 1 |
| Du, J | 1 |
| Bai, Y | 1 |
| Yeh, SC | 1 |
| Sahli, S | 1 |
| Andrews, DW | 1 |
| Patterson, MS | 1 |
| Armstrong, D | 1 |
| Provias, J | 1 |
| Fang, Q | 1 |
| Gross, SA | 1 |
| Wolfsen, HC | 2 |
| Zhao, P | 1 |
| Chen, F | 1 |
| Luo, R | 1 |
| Davila, ML | 1 |
| Dunn, JM | 1 |
| Mackenzie, GD | 1 |
| Banks, MR | 1 |
| Mosse, CA | 1 |
| Green, S | 1 |
| Rodriguez-Justo, M | 1 |
| Winstanley, A | 1 |
| Novelli, MR | 1 |
| Bown, SG | 4 |
| Lovat, LB | 1 |
| Ortner, M- | 1 |
| Zumbusch, K | 2 |
| Liebetruth, J | 1 |
| Ebert, B | 2 |
| Fleige, B | 2 |
| Dietel, M | 2 |
| Lochs, H | 3 |
| Brand, S | 1 |
| Wang, TD | 1 |
| Schomacker, KT | 1 |
| Poneros, JM | 1 |
| Lauwers, GY | 1 |
| Compton, CC | 1 |
| Pedrosa, MC | 1 |
| Nishioka, NS | 2 |
| Ortner, MA | 1 |
| Hein, E | 1 |
| Nolte, D | 1 |
| Sukowski, U | 1 |
| Weber-Eibel, J | 1 |
| Stolte, M | 4 |
| Oberhuber, G | 1 |
| Porschen, R | 1 |
| Klump, B | 1 |
| Hörtnagl, H | 1 |
| Rinneberg, H | 1 |
| Höpfner, M | 1 |
| Maaser, K | 1 |
| Theiss, A | 1 |
| Lenz, M | 1 |
| Sutter, AP | 1 |
| Kashtan, H | 3 |
| von Lampe, B | 1 |
| Riecken, EO | 1 |
| Zeitz, M | 1 |
| Scherübl, H | 1 |
| Stepinac, T | 1 |
| Felley, C | 1 |
| Jornod, P | 1 |
| Lange, N | 1 |
| Gabrecht, T | 1 |
| Fontolliet, C | 1 |
| Grosjean, P | 1 |
| vanMelle, G | 1 |
| van den Bergh, H | 2 |
| Monnier, P | 2 |
| Wagnières, G | 2 |
| Dorta, G | 1 |
| Prosst, RL | 1 |
| Gahlen, J | 1 |
| Claydon, PE | 1 |
| Ackroyd, R | 1 |
| Pech, O | 2 |
| Gossner, L | 6 |
| May, A | 5 |
| Rabenstein, T | 1 |
| Vieth, M | 1 |
| Berres, M | 1 |
| Ell, C | 6 |
| Ji, Z | 2 |
| Yang, G | 2 |
| Shahzidi, S | 1 |
| Tkacz-Stachowska, K | 1 |
| Suo, Z | 2 |
| Nesland, JM | 2 |
| Peng, Q | 2 |
| Vasovic, V | 1 |
| Cunderlikova, B | 1 |
| Eickhoff, A | 1 |
| Jakobs, R | 2 |
| Weickert, U | 1 |
| Hartmann, D | 1 |
| Schilling, D | 1 |
| Alsenbesy, M | 1 |
| Eickhoff, JC | 1 |
| Riemann, JF | 2 |
| Sroka, R | 4 |
| Hahn, EG | 5 |
| Regula, J | 2 |
| MacRobert, AJ | 2 |
| Gorchein, A | 1 |
| Buonaccorsi, GA | 1 |
| Thorpe, SM | 1 |
| Spencer, GM | 1 |
| Hatfield, AR | 1 |
| Millson, CE | 2 |
| Rick, K | 1 |
| Ortner, M | 1 |
| Messmann, H | 4 |
| Knüchel, R | 2 |
| Endlicher, E | 2 |
| Hauser, T | 1 |
| Szeimies, RM | 1 |
| Kullmann, F | 1 |
| Bäumler, W | 1 |
| Schölmerich, J | 2 |
| Mĺkvy, P | 1 |
| Conio, M | 1 |
| Pauer, M | 1 |
| Hinnen, P | 2 |
| de Rooij, FW | 2 |
| van Velthuysen, ML | 1 |
| Edixhoven, A | 2 |
| van Hillegersberg, R | 3 |
| Tilanus, HW | 2 |
| Wilson, JH | 2 |
| Siersema, PD | 3 |
| Wang, KK | 1 |
| Fennerty, MB | 1 |
| Konikoff, F | 2 |
| Haddad, R | 2 |
| Skornick, Y | 2 |
| Orth, K | 1 |
| Stanescu, A | 1 |
| Rück, A | 1 |
| Russ, D | 1 |
| Beger, HG | 1 |
| Mayinger, B | 2 |
| Reh, H | 2 |
| Hochberger, J | 1 |
| Keller, R | 1 |
| Fischbach, W | 1 |
| van den Boogert, J | 1 |
| van Staveren, HJ | 1 |
| de Bruin, RW | 1 |
| Eikelaar, JH | 1 |
| Radu, A | 1 |
| Terlouw, EM | 1 |
| van Dekken, H | 1 |
| Umansky, M | 1 |
| Halpern, Z | 1 |
| Fürst, A | 1 |
| Zöpf, T | 1 |
| Rosenbaum, A | 1 |
| Apel, D | 1 |
| Arnold, JC | 1 |
| Maier, A | 2 |
| Tomaselli, F | 2 |
| Matzi, V | 2 |
| Rehak, P | 2 |
| Pinter, H | 2 |
| Smolle-Jüttner, FM | 2 |
| Neidhardt, S | 1 |
| Martus, P | 1 |
| Eisendrath, P | 1 |
| Van Laethem, JL | 1 |
| Hellmig, S | 1 |
| Fölsch, UR | 1 |
| Nagy, CD | 1 |
8 reviews available for aminolevulinic acid and Esophageal Neoplasms
| Article | Year |
|---|---|
The role of photodynamic therapy in the esophagus.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasm | 2010 |
Photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasm | 2011 |
Photodynamic therapy for esophageal diseases: a clinical update.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Endosonography; Eso | 2003 |
5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Clinical Trials as Topic; Esophageal Neoplas | 2004 |
Photodynamic therapy using 5-aminolaevulinic acid for the treatment of dysplasia in Barrett's oesophagus.
Topics: Administration, Oral; Aminolevulinic Acid; Animals; Barrett Esophagus; Controlled Clinical Trials as | 2008 |
Current status of photodynamic therapy of Barrett's esophagus.
Topics: Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Epithelium; Esophageal Neoplasms; H | 1999 |
[Fluorescence endoscopy in gastroenterology].
Topics: Aminolevulinic Acid; Barrett Esophagus; Colitis, Ulcerative; Colonic Neoplasms; Endoscopy, Gastroint | 2000 |
Photodynamic therapy of early squamous cell cancers of the esophagus.
Topics: Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Squamous Cell; Dihematoporphyrin Ether; Drug | 2000 |
6 trials available for aminolevulinic acid and Esophageal Neoplasms
| Article | Year |
|---|---|
Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett's oesophagus related neoplasia.
Topics: Adenocarcinoma; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Catheter Ablation; Dihematoporp | 2018 |
A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Dihematoporphyrin Ether; Disease Progr | 2013 |
Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Colorectal Neoplasms; Duodenal Neoplasms; Esoph | 1995 |
Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Topics: Adult; Aged; Aminolevulinic Acid; Dihematoporphyrin Ether; Duodenal Neoplasms; Esophageal Neoplasms; | 1998 |
Photodynamic therapy of cancer of the esophagus using systemic aminolevulinic acid and a non laser light source: a phase I/II study.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squam | 1999 |
Does new photosensitizer improve photodynamic therapy in advanced esophageal carcinoma?
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Deglutition | 2001 |
38 other studies available for aminolevulinic acid and Esophageal Neoplasms
| Article | Year |
|---|---|
Accumulation of Uroporphyrin I in Necrotic Tissues of Squamous Cell Carcinoma after Administration of 5-Aminolevulinic Acid.
Topics: Aged; Aminolevulinic Acid; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatography, High | 2021 |
Antitumor Effect of 5-Aminolevulinic Acid Through Ferroptosis in Esophageal Squamous Cell Carcinoma.
Topics: Aminolevulinic Acid; Animals; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Ferroptosis; | 2021 |
Influence and mechanism of 5-aminolevulinic acid-photodynamic therapy on the metastasis of esophageal carcinoma.
Topics: Aminolevulinic Acid; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Chromones; Down-Regulation | 2017 |
Dihydroartemisinin Increases the Sensitivity of Photodynamic Therapy Via NF-κB/HIF-1α/VEGF Pathway in Esophageal Cancer Cell in vitro and in vivo.
Topics: Aminolevulinic Acid; Animals; Artemisinins; Cell Line, Tumor; Cell Proliferation; Esophageal Neoplas | 2018 |
5-Aminolevulinic acid induced protoporphyrin IX as a fluorescence marker for quantitative image analysis of high-grade dysplasia in Barrett's esophagus cellular models.
Topics: Adenocarcinoma; Algorithms; Aminolevulinic Acid; Barrett Esophagus; Biomarkers; Esophageal Neoplasms | 2015 |
Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer.
Topics: Aminolevulinic Acid; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Prolifer | 2011 |
Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
Topics: Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Pho | 2002 |
Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esopha | 2002 |
Time gated fluorescence spectroscopy in Barrett's oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Biomarkers, | 2003 |
Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Carcinoma, Squam | 2003 |
Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid.
Topics: Administration, Oral; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Carcinoma in Situ; Esopha | 2003 |
Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Disease-Free Survival; Esophageal Neop | 2005 |
Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cell Differentiation; Cell Survival; Cells, Cultured; | 2006 |
Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; | 2006 |
Long-Segment early squamous cell carcinoma of the proximal esophagus: curative treatment and long-term follow-up after 5-aminolevulinic acid (5-ALA)-photodynamic therapy.
Topics: Aminolevulinic Acid; Biopsy; Carcinoma, Squamous Cell; Disease-Free Survival; Endoscopy, Gastrointes | 2006 |
Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid.
Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Aminolevulinic Acid; Esophageal Neopl | 1995 |
Photodynamic therapy in gastroenterology.
Topics: Aminolevulinic Acid; Animals; Esophageal Neoplasms; Gastroenterology; Helicobacter Infections; Helic | 1997 |
Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Female | 1998 |
Drug, light, and oxygen: a dynamic combination in the clinic.
Topics: Aminolevulinic Acid; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Esophageal N | 1998 |
[Photodynamic therapy of early squamous epithelial carcinomas and severe squamous epithelial dysplasias of the esophagus with 5-aminolevulinic acid].
Topics: Administration, Oral; Aged; Aminolevulinic Acid; Carcinoma, Squamous Cell; Esophageal Neoplasms; Eso | 1998 |
[Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Fe | 1998 |
[Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid. A pilot study].
Topics: Adenoma; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Colitis, Ulcerative; Colorectal Neopla | 1998 |
Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
Topics: Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Female; Ferroc | 1998 |
Perspectives on endoscopic eradication of Barrett's esophagus: who are appropriate candidates and what is the best method?
Topics: Aminolevulinic Acid; Barrett Esophagus; Biopsy; Electrocoagulation; Endoscopy; Endoscopy, Gastrointe | 1999 |
[Photodynamic ablation and argon-plasma coagulation of premalignant and early-stage malignant lesions of the oesophagus--an alternative to surgery?].
Topics: Aged; Aminolevulinic Acid; Argon; Barrett Esophagus; Carcinoma; Esophageal Neoplasms; Female; Humans | 1999 |
Endoscopic photodynamic diagnosis: oral aminolevulinic acid is a marker of GI cancer and dysplastic lesions.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Duodenal Neoplasms; Endoscopy, Digesti | 1999 |
A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Carcinoma, Squamous Cell; Card | 1999 |
[Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis or colorectal adenomas].
Topics: Adenomatous Polyps; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Colitis, Ulcerative; Colorectal | 1999 |
Photodynamic therapy for esophageal lesions: selectivity depends on wavelength, power, and light dose.
Topics: Aminolevulinic Acid; Animals; Carcinoma, Squamous Cell; Esophageal Neoplasms; Esophagus; Hematoporph | 1999 |
Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett E | 2000 |
[Photodynamic therapy for dysphagia due to esophageal carcinoma].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Deglutition | 1999 |
[Endoscopic fluorescence diagnosis of esophageal carcinoma after sensitization with 5-aminolevulinic acid].
Topics: Adenocarcinoma; Aminolevulinic Acid; Barrett Esophagus; Diagnosis, Differential; Esophageal Neoplasm | 2001 |
[Photodynamic therapy of dysplasias and early carcinomas in Barrett esophagus with a diode laser system--a pilot study].
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Cell Transformation, Neoplastic; Esoph | 2001 |
Photosensitization with hematoporphyrin derivative compared to 5-aminolaevulinic acid for photodynamic therapy of esophageal carcinoma.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Esophageal N | 2001 |
Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions.
Topics: Administration, Oral; Aged; Aminolevulinic Acid; Biopsy; Esophageal Neoplasms; Esophagoscopy; Female | 2001 |
Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitization.
Topics: Administration, Oral; Administration, Topical; Aminolevulinic Acid; Barrett Esophagus; Cell Transfor | 2002 |
[5-aminolevulinic acid induced fluorescence for the detection of oesophageal lesions].
Topics: Aminolevulinic Acid; Esophageal Neoplasms; Esophagoscopy; Esophagus; Fluorescence; Humans; Precancer | 2002 |
Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Barrett Esophagus; Esophageal Neoplasms; Humans; Mice; | 2002 |